|
National Stock Number(NSN): 6505-01-703-3779 (6505017033779, 017033779)
| NIIN: |
01-703-3779 |
Item Name: |
CORONAVIRUS VACCINE |
INC: |
80837
|
| FSC: |
6505
|
Assignment Date: |
Sep-01-2022 |
CRIT: |
X |
IIG: |
80837 |
| ISC: |
5 |
Date Standardized: |
Sep-01-2022 |
HMIC: |
P |
DODIC: |
|
| NSC: |
4 |
Cancellation Date: |
Nov-01-2022 |
PMIC: |
A |
FIIG: |
T088-E |
| ESD: |
|
Schedule B: |
|
DEMIL: |
A |
DEMIL INT: |
1 |
| TIIC: |
4 |
Originator: |
97 |
ADPEC: |
0 |
RPDMRC: |
5 |
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
1639053 |
89875
|
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA |
H |
5 |
1 |
4 |
ZZ |
|
|
|
|
|
|
|
6505NCM228591 |
64616
|
DEFENSE MEDICAL STANDARDIZATION BOARD |
H |
3 |
1 |
4 |
ZZ |
|
|
|
|
|
|
|
NDC80777-0282-05 |
8PTM0
|
MODERNA US, INC. |
H |
3 |
2 |
4 |
ZZ |
|
K |
|
|
|
|
| MOEC |
SOS |
A A C |
R C |
S L C |
CIIC |
U P Q |
U S C |
Unit Price |
UI |
UICF |
MCD |
Action Date |
C/H |
| DA |
SMS |
L |
|
0 |
U |
1 |
A |
$0.01 |
EA |
|
C2203X- |
Sep-01-2022 |
H |
| DF |
SMS |
L |
|
0 |
U |
1 |
F |
$0.01 |
EA |
|
------- |
Sep-01-2022 |
H |
| DM |
SMS |
L |
Z |
0 |
U |
1 |
M |
$0.01 |
EA |
|
1-54--- |
Sep-01-2022 |
H |
| DN |
SMS |
L |
|
0 |
U |
1 |
N |
$0.01 |
EA |
|
9B----- |
Sep-01-2022 |
H |
| DS |
SMS |
L |
|
0 |
U |
1 |
D |
$0.01 |
EA |
|
------- |
Sep-01-2022 |
H |
| DS |
SMS |
L |
|
0 |
U |
1 |
I |
$0.01 |
EA |
|
------- |
Sep-01-2022 |
H |
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| AFJQ |
STORAGE TEMP RANGE |
-50.0 TO -15.0 CELSIUS |
| AJCN |
PROTECTIVE STORAGE FEATURE |
PROTECT FROM LIGHT |
| CMDL |
VALENCE |
BIVALENT |
| CMDM |
VIRUS STRAIN |
COVID 19 |
| CQCT |
PRIMARY CONTAINER TYPE |
VIAL, MULTIPLE DOSE |
| CSCW |
TOTAL PRIMARY CONTAINER QUANTITY |
1 |
| CSGS |
ADMINISTRATION |
INJECTION |
| CXCY |
PART NAME ASSIGNED BY CONTROLLING AGENCY |
MODERNA COVID-19 VACCINE, BIVALENT, BOOSTER |
| FEAT |
SPECIAL FEATURES |
INDICATED FOR ACTIVE IMMUNIZATION TO PREVENT CORONAVIRUS DISEASE 2019 (COVID-19) CAUSED BY SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2); BOOSTER DOSE: 0.5 ML OR 0.25 ML BASED ON AGE; ORIGINAL AND OMICRON BA.4/BA.5; SUSPENSION FOR INTRAMUSCULAR INJECTION; STORE FROZEN BETWEEN -50 C TO -15 C (-58 F TO 5 F); AFTER FIRST USE STORE AT 2C TO 25C (35F TO 77F) AND DISCARD AFTER 12 HOURS; PROTECT FROM LIGHT; MULTIDOSE VIAL; FOR USE UNDER EMERGENCY USE AUTHORIZATION; BOOSTER DOSES ONLY. |
| MOE Rule |
Former MOER |
Effective |
AMC |
AMSC |
IMC |
IMCA |
Collaborators |
Receivers |
| A911 |
|
Sep-01-2022 |
0 |
0 |
|
|
AM|GX |
AM|BN|GX |
| N9BL |
|
Sep-01-2022 |
0 |
0 |
|
|
GX |
GH|GX |
| MC55 |
|
Sep-01-2022 |
0 |
0 |
|
|
GX|PA |
GX|PA |
| FSGM |
|
Sep-01-2022 |
0 |
0 |
|
|
GX|TT |
GX|SS|TT |
|